Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Tax Provisions (2023 - 2025)

Historic Tax Provisions for OptimizeRx (OPRX) over the last 3 years, with Q3 2025 value amounting to $270000.0.

  • OptimizeRx's Tax Provisions rose 13304.77% to $270000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 10575.92%. This contributed to the annual value of -$4.1 million for FY2024, which is 4642.01% up from last year.
  • As of Q3 2025, OptimizeRx's Tax Provisions stood at $270000.0, which was up 13304.77% from $181000.0 recorded in Q2 2025.
  • OptimizeRx's 5-year Tax Provisions high stood at $344000.0 for Q1 2024, and its period low was -$2.5 million during Q4 2024.
  • Over the past 3 years, OptimizeRx's median Tax Provisions value was -$392000.0 (recorded in 2023), while the average stood at -$584000.0.
  • Its Tax Provisions has fluctuated over the past 5 years, first tumbled by 339696.97% in 2024, then skyrocketed by 13304.77% in 2025.
  • Quarter analysis of 3 years shows OptimizeRx's Tax Provisions stood at $33000.0 in 2023, then crashed by 7706.06% to -$2.5 million in 2024, then skyrocketed by 110.76% to $270000.0 in 2025.
  • Its Tax Provisions was $270000.0 in Q3 2025, compared to $181000.0 in Q2 2025 and -$1.1 million in Q1 2025.